US 12129471
Materials and methods for treatment of human genetic diseases including hemoglobinopathies
granted A61KA61K48/005A61P
Quick answer
US patent 12129471 (Materials and methods for treatment of human genetic diseases including hemoglobinopathies) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K48/005, A61P, A61P7/06